Aileron Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ALRN and other ETFs, options, and stocks.About ALRN
Aileron Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of a novel class of therapeutics for the treatment of cancer and other diseases. It focuses on its lead product candidate, ALRN-6924, which is a cell-permeating peptide that disrupts the interaction of p53 suppressors MDM2 and MDMX with tumor suppressor p53 to reactivate tumor suppression in non-mutant, or wild-type, p53 cancers.
CEOBrian J. Windsor
CEOBrian J. Windsor
Employees15
Employees15
HeadquartersAustin, Texas
HeadquartersAustin, Texas
Founded2001
Founded2001
Employees15
Employees15
ALRN Key Statistics
Market cap63.53M
Market cap63.53M
Price-Earnings ratio-1.11
Price-Earnings ratio-1.11
Dividend yield—
Dividend yield—
Average volume170.05K
Average volume170.05K
High today$4.17
High today$4.17
Low today$3.75
Low today$3.75
Open price$3.79
Open price$3.79
Volume142.70K
Volume142.70K
52 Week high$7.42
52 Week high$7.42
52 Week low$1.01
52 Week low$1.01